Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125580201 | 12558020 | 1 | I | 201606 | 20160712 | 20160714 | 20160714 | PER | US-ELI_LILLY_AND_COMPANY-US201607004366 | ELI LILLY AND CO | 67.37 | YR | M | Y | 0.00000 | 20160714 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125580201 | 12558020 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, BID | 21427 | 60 | MG | CAPSULE | BID | ||||||
| 125580201 | 12558020 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 21427 | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125580201 | 12558020 | 1 | Anxiety |
| 125580201 | 12558020 | 2 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125580201 | 12558020 | Chills | |
| 125580201 | 12558020 | Hyperhidrosis | |
| 125580201 | 12558020 | Intentional product misuse | |
| 125580201 | 12558020 | Nausea | |
| 125580201 | 12558020 | Pyrexia | |
| 125580201 | 12558020 | Resting tremor | |
| 125580201 | 12558020 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125580201 | 12558020 | 1 | 2014 | 201606 | 0 |